BlackBerry Limited (BB) Stock Price Today
Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
Christmas flight prices from the UK drop up to 39% for 2026, with US destinations leading the decline.
Flight prices from the UK for Christmas and New Year 2026 have decreased by up to 39% compared to last year, according to KAYAK. US cities like Atlanta, Washington DC, and Los Angeles show the largest drops, with Atlanta fares down 39%. Short-haul Eu...
Lazard appoints David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure
Lazard has appointed David Krap as Managing Director and Co-Head of its European Consumer, Retail & Leisure division. Krap brings over 20 years of M&A advisory experience, especially in food, beverage, and consumer health sectors, joining from J.P. M...
Elbit Systems wins $235M contract to supply medium-range rockets and launchers to a European country.
Elbit Systems has secured a $235 million contract to provide EXTRA-MR medium-range rockets and PULS rocket artillery systems to a European government under a government-to-government deal. The contract spans three years and includes supply of precisi...
GSK's lung cancer drug shows 61% response rate in early global trial at higher dose
GSK announced that its experimental lung cancer drug, risvutatug rezetecan, achieved a 61% confirmed response rate at the higher 8 mg/kg dose in an early global trial involving patients with relapsed extensive-stage small cell lung cancer. This respo...
Senior loans and Franklin Senior Loan ETF benefit from wider credit spreads and Fed rate hikes.
Senior loans are expected to perform well due to wider credit spreads and recent Federal Reserve interest rate hikes. The Franklin Senior Loan ETF (FLBL) stands out as a strong option in this category, offering a growing dividend yield of 7.6%. This ...
Oil supply risks grow as US eases Russia sanctions amid attacks on Gulf and Russian oil infrastructure.
The US has temporarily eased sanctions on Russian crude oil, suspending duties that could have reached 100% on major buyers, potentially increasing supply. However, oil supply risks have widened due to attacks on tankers and oil infrastructure in the...
Oculis completes patient randomization in trial for precision medicine Licaminlimab targeting dry eye disease.
Oculis Holding AG has completed patient randomization in its PREDICT-1 trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). The trial enrolled 176 patients, two-thirds carrying a genetic variant linked to b...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.